Compare NBTX & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | STGW |
|---|---|---|
| Founded | 2003 | 1980 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2018 | 2006 |
| Metric | NBTX | STGW |
|---|---|---|
| Price | $32.60 | $11.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $54.24 | $12.86 |
| AVG Volume (30 Days) | 136.4K | ★ 2.1M |
| Earning Date | 09-24-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,909,000,000.00 |
| Revenue This Year | N/A | $11.94 |
| Revenue Next Year | $50.69 | $2.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.39 |
| 52 Week Low | $19.14 | $4.29 |
| 52 Week High | $57.14 | $12.26 |
| Indicator | NBTX | STGW |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 73.86 |
| Support Level | $30.73 | $8.21 |
| Resistance Level | $35.17 | N/A |
| Average True Range (ATR) | 1.84 | 0.58 |
| MACD | 0.56 | 0.16 |
| Stochastic Oscillator | 72.25 | 75.93 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.